Medical Stores Department Pharmaceutical Import Profile — Tanzania (DGFT 2022–2026)

Name: Medical Stores Department Pharmaceutical Import Records from India — 3 Products, $500.0K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Medical Stores Department — Pharmaceutical Importer Profile (2026) | 3 Products, $500.0K Trade | TransData Nexus

Medical Stores Department

Pharmaceutical Importer · Tanzania · Antibiotics Focus · $500.0K Total Trade · DGFT Verified

Medical Stores Department is a pharmaceutical importer based in Tanzania with a total trade value of $500.0K across 3 products in 3 therapeutic categories. Based on 10 verified import shipments from Indian Customs (DGFT) records, Medical Stores Department is the #1 buyer in 1 product including Captopril. Medical Stores Department sources from 22 verified Indian suppliers, with Lincoln Pharmaceuticals Limited accounting for 28.3% of imports.

Medical Stores Department — Import Portfolio & Supplier Network

Medical Stores Department import network — 3 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Medical Stores Department?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Lincoln Pharmaceuticals Limited	$1.4M	35	28.3%
Medopharm Private Limited	$711.7K	15	14.8%
Venor Pharma Limited	$428.6K

What Formulations Does Medical Stores Department Import?

Formulation	Value	Ships
Chlorphenamine tablets BP (chlormine)	$150.0K	3
Medomox 250 dt (amoxicillin tablets	$150.0K	3
Medomox 250 dt amoxicillin tablets	$150.0K	3
Erythromycin stearate tablets BP 250MG (70000 x 10 x 10) -	$150.0K	3
Captopril tablets BP (capril-25)	$142.6K	3
Dicyclomine hci with paracetamol	$112.0K	3
Pharmaceuticals-brand.verzepam INJ.diazepam BP 5MG/ML,2ML ampoule.bn.ep452309,ep452310 , ep452315 md.nov/23	$109.7K	3
(msn pharmaceuticals) ramgic (tramadol injection 50MG/ML) 1x10s	$105.5K	3
Albendazole suspension 200 MG/ 5 ML	$102.3K	3
Filazol 200 tablets (albendazole	$100.0K	2
Meropenem for injection 1 g/vial	$100.0K	2
Sulphadoxine & pyrimethamine tablets	$100.0K	2
Brand.verpat INJ.pethidine hcl BP 50 MG/ML,1ML ampoule bn.en052305,en052306,en052307,en052309 md.dec/2023	$68.4K	3
Brand.verbital INJ.phenobarbital sodiumbp 100MG/ML,2ML amp. bn.ep1842401,ep1842402,ep1842403 md.feb/2024	$66.0K	3
Koact tablets 375MG (co-amoxiclav	$50.0K	1

Medical Stores Department imports 141 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 3 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Erythromycin	Antibiotics	$250.0K	5	0.3%	5
2	Captopril	Cardiovascular	$150.0K	3	1.2%	1
3	Pyrimethamine	Antimalarial & Antiparasitic	$100.0K	2	0.2%	7

Medical Stores Department imports 3 pharmaceutical products across 3 categories into Tanzania totaling $500.0K. The company is the #1 buyer for 1 product: Captopril.

Medical Stores Department — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

The Medical Stores Department (MSD) is an autonomous government agency under Tanzania's Ministry of Health, established by Act No. 13 of 1993. Its primary mandate is to develop, maintain, and manage an efficient and cost-effective system for the procurement, storage, and distribution of approved medicines and medical supplies to public health facilities across the country. (msd.go.tz)

Headquartered in Dar es Salaam, Tanzania, MSD operates through ten zonal stores located in Dar es Salaam, Mwanza, Iringa, Kilimanjaro, Mbeya, Tabora, Dodoma, Tanga, Mtwara, and Kagera. This extensive network ensures the timely and reliable delivery of health commodities to various regions, supporting the nation's public health infrastructure. (msd.go.tz)

2Distribution Network

MSD's distribution network is strategically designed to cover the entire Tanzanian territory. With ten zonal stores and additional sales points in Tanga and Muleba, the department ensures that health commodities are accessible to all public health facilities nationwide. This widespread presence facilitates efficient logistics and timely delivery of medical supplies, contributing to the overall effectiveness of Tanzania's healthcare system. (msd.go.tz)

3Industry Role

In Tanzania's pharmaceutical supply chain, MSD functions as the primary wholesaler and distributor of medical supplies to public health facilities. By managing the procurement, storage, and distribution of health commodities, MSD plays a pivotal role in ensuring the availability of essential medicines and medical supplies across the country. This centralized approach enhances the efficiency and reliability of the healthcare supply chain, directly impacting the quality of care provided to the Tanzanian population. (msd.go.tz)

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Medical Stores Department

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

MSD's sourcing strategy reveals a significant concentration in its supplier base, with a total import value of $500K USD from India across 10 shipments. The top three products imported are Captopril ($150K), Erythromycin ($250K), and Pyrimethamine ($100K), accounting for 1.2%, 0.3%, and 0.2% of the total import value, respectively. This concentration indicates a strategic choice to source specific products from a limited number of suppliers, potentially streamlining procurement processes and ensuring consistent quality. However, such dependency may pose risks if any of these suppliers face operational challenges or regulatory issues.

The shipment data, comprising 35 shipments from Lincoln Pharmaceuticals Limited and 15 from Medopharm Private Limited, suggests a stable and ongoing relationship with these suppliers. The consistent volume and frequency of shipments indicate a reliable supply chain, which is crucial for maintaining the uninterrupted availability of essential medicines. Nonetheless, the limited number of suppliers could be a vulnerability if there are disruptions in their operations or if they are unable to meet MSD's demand.

2Supply Chain Resilience

MSD's supply chain resilience is closely tied to its sourcing strategy from Indian suppliers. The department's reliance on a select group of suppliers for key products suggests a streamlined procurement process but also highlights potential vulnerabilities. The absence of backup suppliers for these critical products could lead to supply disruptions if any primary supplier encounters issues. Additionally, the limited diversity in product formulations imported from India may restrict MSD's ability to adapt to changing market demands or regulatory requirements.

Importing Pharmaceuticals into Tanzania — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Tanzania

1Regulatory Authority & Framework

The Tanzania Medicines and Medical Devices Authority (TMDA) is the primary regulatory body overseeing the importation and exportation of medicines, medical devices, and related products in Tanzania. Established under the Tanzania Medicines and Medical Devices Act Cap. 219, TMDA is responsible for ensuring that all pharmaceutical products imported into the country are safe, effective, and of high quality. (tmda.go.tz)

Key legislation governing pharmaceutical imports includes the Tanzania Medicines and Medical Devices Act Cap. 219, which outlines the regulatory framework for the importation, registration, and distribution of medical products. This Act mandates that all pharmaceutical products must be registered with TMDA before importation and sets forth the conditions for import permits, including requirements related to product shelf-life and storage conditions. (tmda.go.tz)

The marketing authorization pathway for Indian generics involves several steps:

1. Product Registration: Indian manufacturers must submit an application to TMDA, providing comprehensive documentation on the product's quality, safety, and efficacy.

2. Import Permit Application: Once registered, importers must apply for an import permit through TMDA's online trader portal, ensuring compliance with all regulatory requirements.

3. Inspection and Approval: TMDA conducts inspections and evaluations to verify compliance with Tanzanian standards before granting approval for importation.

2Import Licensing & GMP

Medical Stores Department — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

MSD's product category focus on antibiotics, cardiovascular drugs, and antimalarial & antiparasitic agents aligns with the prevalent health challenges in Tanzania. The substantial import value of Captopril ($150K) and Ery

TransData Nexus Research · DGFT trade data analysisMar 2026

Frequently Asked Questions — Medical Stores Department

What products does Medical Stores Department import from India?

Medical Stores Department imports 3 pharmaceutical products across 3 categories. Top imports: Erythromycin ($250.0K), Captopril ($150.0K), Pyrimethamine ($100.0K).

Who supplies pharmaceuticals to Medical Stores Department from India?

Medical Stores Department sources from 22 verified Indian suppliers. The primary supplier is Lincoln Pharmaceuticals Limited (28.3% of imports, $1.4M).

What is Medical Stores Department's total pharmaceutical import value?

Medical Stores Department's total pharmaceutical import value from India is $500.0K, based on 10 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Medical Stores Department focus on?

Medical Stores Department imports across 3 categories. The largest: Antibiotics (50.0%), Cardiovascular (30.0%), Antimalarial & Antiparasitic (20.0%).

Get Full Medical Stores Department Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Profile aggregates 2 company name variants from customs records. For current shipment-level data, contact TransData Nexus.